Document is current
Any future updates will be listed below
-
Authors
Kalbe, Elke https://orcid.org/0000-0001-8603-2545
Folkerts, Ann-Kristin https://orcid.org/0000-0003-2168-140X
Witt, Karsten https://orcid.org/0000-0002-9384-3474
Buhmann, Carsten https://orcid.org/0000-0001-8540-3789
Liepelt-Scarfone, Inga https://orcid.org/0000-0002-0875-892X
,
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 10 April 2024
Revised: 3 June 2024
Accepted: 7 June 2024
First Online: 9 August 2024
Declarations
:
: EK has received grants from the German Ministry of Education and Research, General Joint Committee, Germany, the German Parkinson Society, and STADAPHARM GmbH; honoraria from AbbVie GmbH Germany; memodio GmbH Germany; license fees from Prolog GmbH, Germany. EK is one of the authors of the cognitive intervention series “NEUROvitalis” but receives no corresponding honoraria. AKF has received grants from the German Parkinson Society, the German Alzheimer’s Society, the German Parkinson Foundation, STADAPHARM GmbH and the General Joint Committee Germany as well as honoraria from Springer Medizin Verlag GmbH, Heidelberg, Germany; Springer-Verlag GmbH, Berlin; ProLog Wissen GmbH, Cologne, Germany; Seminar- und Fortbildungszentrum Rheine, Germany; LOGOMANIA, Fendt & Sax GbR, Munich, Germany; LOGUAN, Ulm, Germany; dbs e.V., Moers, Germany; STADAPHARM GmbH, Bad Vilbel, Germany; NEUROPSY, St. Konrad, Austria; Multiple Sclerosis Society Vienna, Vienna, Austria; and Gossweiler Foundation, Bern, Switzerland. AKF is one of the authors of the cognitive intervention series “NEUROvitalis” but receives no corresponding honoraria. CB reports fees for lectures and/or honour boards from AbbVie, Bial, Desitin, Kyowa Kirin, Merz, STADA Pharma, TAD Pharma, UCB, Zambon. He has received royalties from Thieme Press and Kohlhammer Press and reports funding from Hilde-Ulrichs-Stiftung für Parkinsonforschung. KW has received funding from the Deutsche Forschungsgemeinschaft (German Research Association) and STADAPHARM GmbH outside the present study. He has received honoraria for presentations/advisory boards/consultations from BIAL, Indorsia, Boston Scientific and STADAPHARM GmbH outside the present study. He has received royalties from Thieme Press and Elsevier Press. He serves as an editorial board member of Wileys “Parkinson’s Disease”, “Behavioural Neurology” and PLOSone. ILS reports funding from Bayer AG and travel grants from and travel grants from Desitin and the German Neurological Society outside the submitted work.
: Not applicable
